Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV

被引:1
|
作者
Kennedy, Amy J. [1 ,14 ]
McGinnis, Kathleen A. [2 ]
Merlin, Jessica S. [1 ]
Edelman, E. Jennifer [3 ,4 ]
Gordon, Adam J. [5 ,6 ]
Korthuis, P. Todd [7 ]
Skanderson, Melissa [2 ]
Williams, Emily C. [8 ,9 ]
Wyse, Jessica [10 ,11 ]
Oldfield, Benjamin [3 ]
Bryant, Kendall [12 ]
Justice, Amy [2 ,3 ]
Fiellin, David A. [3 ,4 ]
Kraemer, Kevin L. [1 ,13 ]
机构
[1] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA
[2] VA Connecticut Healthcare Syst, West Haven, CT USA
[3] Yale Sch Med, Dept Internal Med, New Haven, CT USA
[4] Yale Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT USA
[5] Univ Utah, Program Addict Res Clin Care Knowledge & Advocacy, Dept Internal Med, Div Epidemiol, Salt Lake City, UT USA
[6] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT USA
[7] Oregon Hlth & Sci Univ, Div Gen Internal Med, Sect Addict Med, Portland, OR 97201 USA
[8] Univ Washington, VA Puget Sound Healthcare Syst, Dept Hlth Serv, Seattle, WA 98195 USA
[9] Seattle Denver Ctr Innovat Vet Centered & Value D, Hlth Serv Res & Dev, VA Puget Sound Healthcare Syst, Seattle, WA USA
[10] VA Portland Healthcare Syst, Portland, OR USA
[11] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA
[12] NIAAA, Bethesda, MD USA
[13] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[14] Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
HIV; Opioid use disorder; Veterans; Medication treatment; Behavioral treatment; SUBSTANCE-ABUSE TREATMENT; CARE; BUPRENORPHINE/NALOXONE; PHARMACOTHERAPY; THERAPY;
D O I
10.1016/j.jsat.2021.108509
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Persons with HIV (PWH) and opioid use disorder (OUD) can have poor health outcomes. We assessed whether intensity of behavioral treatment for OUD (BOUD) with and without medication for OUD (MOUD) is associated with improved HIV clinical outcomes. Methods: We used Veterans Aging Cohort Study (VACS) data from 2008 to 2017 to identify PWH and OUD with 0.01). VL, CD4 count and VACS Index 2.0 did not differ by BOUD or 6 months of MOUD treatment. Conclusion: Among PWH and OUD who initiated BOUD, higher intensity BOUD was associated with improved ART initiation and adherence, but neither BOUD alone nor BOUD plus >6 months MOUD was associated with improvements in VL, CD4 count or VACS Index 2.0.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] ALCOHOL AND ILLICIT SUBSTANCE USE IMPACT TREATMENT OUTCOMES AMONG PATIENTS RECEIVING OUTPATIENT MEDICATION-ASSISTED TREATMENT FOR OPIOID USE DISORDER
    Van Dyke, N.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 : 134A - 134A
  • [42] Medication-assisted treatment for opioid use disorder
    Kaplan, Louise
    [J]. NURSE PRACTITIONER, 2019, 44 (03): : 10 - 12
  • [43] Medication for the Treatment of Opioid Use Disorder in Pregnancy Is Essential
    Poland, Cara
    Stoltman, Jonathan J. K.
    Felton, Julia W.
    [J]. JAMA INTERNAL MEDICINE, 2024, 184 (03) : 254 - 255
  • [44] Patient-provider relationships: Opioid use disorder and HIV treatment in Vietnam
    Ardman, Eric
    Brown, Patrick C. M.
    Thuy, Dinh Thi Thanh
    Hang, Nguyen Thu
    Mai, Pham Phuong
    Bart, Gavin
    Hoffman, Kim
    Korthuis, P. Todd
    Giang, Le Minh
    [J]. DRUG AND ALCOHOL DEPENDENCE REPORTS, 2023, 7
  • [45] Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare
    Gibbons, Jason B.
    Mccullough, Jeffrey S.
    Zivin, Kara
    Brown, Zach Y.
    Norton, Edward C.
    [J]. JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 157
  • [46] Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder
    Huhn, Andrew S.
    Berry, Meredith S.
    Dunn, Kelly E.
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2019, 28 (04): : 246 - 261
  • [47] IMPACT OF IMPAIRED COGNITIVE FUNCTIONING AMONG PERSONS ON MEDICATION FOR OPIOID USE DISORDER
    Mistler, Colleen
    Copenhaver, Michael
    Shrestha, Roman
    Gunstad, John
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [48] Association between hazardous alcohol use and initiation of naltrexone treatment for opioid use disorder among hiv-positive persons in russia
    Vetrova, M.
    Blokhina, E. A.
    Cheng, D. M.
    Truong, V.
    Quinn, E. K.
    Gnatienko, N.
    Bushara, N. M.
    Palatkin, V. Y.
    Vasilyeva, J. V.
    Yaroslavtseva, T. S.
    Krupitsky, E. M.
    Lioznov, D. A.
    Samet, J. H.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S228 - S229
  • [49] Evaluation of the Impact of HIV Serostatus on the Hepatitis C Virus Care Cascade and Injection Drug Use Among Persons Initiating Medication Treatment for Opioid Use Disorder (vol 9, ofac624, 2022)
    Lier, A. J.
    Wyk, Vander B.
    Di Paola, A.
    Springer, S. A.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (05):
  • [50] The impact of psychiatric symptoms, drug use, and medication regimen on nonadherence to HIV treatment
    Ingersoll, K
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2004, 16 (02): : 199 - 211